05.03.2015 • NewsAmineBASFChina

BASF Expanding Specialty Amines Output at Ludwigshafen

BASF said it is investing a double-digit million euro to "significantly expand" its capacity for about 20 specialty amines at the Ludwigshafen headquarters site. The products are used to manufacture coatings, lubricants, crop protection products and pharmaceuticals.

The expanded capacity is planned to go on stream gradually from early 2017 and strengthen the German group' worldwide amine production network, including - in addition to Ludwigshafen - plants at Schwarzheide, Germany, Antwerp, Belgium, Geismar, Louisiana, USA, and Nanjing, China.

Two new multiple-product plants for specialty amines announced last year are due to start up later this year at Ludwigshafen and Nanjing, China.

This investment will allow BASF to meet the growing demand from European customers and strengthen its leading market position, said Stefan Blank, president of the group's Intermediates division.

With about 200 different amines, BASF claims to have the world's most diverse portfolio of this type of chemical intermediate.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.